Bone Biologics share price today

(BBLG)

Bone Biologics share price is $0.95 & ₹81.01 as on 27 Dec 2024, 2.30 'hrs' IST

$0.95

▲

0.05

(5.54%)

Market is closed - opens 8 PM, 27 Dec 2024

View live Bone Biologics share price in Dollar and Rupees. Guide to invest in Bone Biologics from India. Also see the sentimental analysis on Indian investors investing in Bone Biologics. Get details on the Indian mutual funds that are investing in Bone Biologics. Get Analyst recommendations and forecasts along with all the Bone Biologics's financials.

Bone Biologics share price movements

Today's Low: $0.88
Today's High: $0.96
$0.95
7.76%
Downside
Day's Volatility :8.72%
Upside
1.04%
52 Weeks Low: $0.80
52 Weeks High: $10.56
$0.95
15.79%
Downside
52 Weeks Volatility :92.42%
Upside
91.0%

Bone Biologics Returns

Period	Bone Biologics Corp	Index (Russel 2000)
3 Months	-61.7%	0.0%
6 Months	-26.22%	0.0%
1 Year	-85.0%	0.0%
3 Years	-99.89%	-21.1%

Bone Biologics Key Statistics

in dollars & INR

Previous Close	$0.9001
Open	$0.898
Today's High	$0.959998
Today's Low	$0.8763
Market Capitalization	$2.2M
Today's Volume	$222.4K
52 Week High	$10.56
52 Week Low	$0.8
Revenue TTM	$0.0
EBITDA	$-825.0K
Earnings Per Share (EPS)	$-1.46
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-119.03%

How to invest in Bone Biologics from India?

It is very easy for Indian residents to invest directly in Bone Biologics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Bone Biologics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Bone Biologics or BBLG on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Bone Biologics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Bone Biologics shares which would translate to 0.898 fractional shares of Bone Biologics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Bone Biologics, in just a few clicks!

Returns in Bone Biologics for Indian investors in Rupees

Investment Value

₹1,00,000

Bone Biologics investment value today

Current value as on today

₹18,158

Returns

₹81,842

(-81.84%)

Returns from Bone Biologics Stock

₹84,167 (-84.17%)

Dollar Returns

₹2,325 (+2.33%)

Indian investors sentiment towards Bone Biologics

-4%

Period: Sep 27, 2024 to Dec 26, 2024. Change in 30 Days versus previous period

Search volume for Bone Biologics on INDmoney from India has reduced in the last 30 days as on Dec 27, 2024. -4% less investors are searching Bone Biologics in the last 30 days versus the previous period.

Global Institutional Holdings in Bone Biologics

UBS Group AG
1.33%
Morgan Stanley - Brokerage Accounts
1.16%
HRT FINANCIAL LLC
0.90%
Tower Research Capital LLC
0.07%
CWM, LLC duplicate
0.02%
McMahon Financial Advisors, LLC
0.02%

Analyst Recommendation on Bone Biologics

Buy

85%Buy

14%Hold

0%Sell

Based on 7 Wall street analysts offering stock ratings for Bone Biologics(by analysts ranked 0 to 5 stars)

Based on 7 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Bone Biologics

What analysts predicted

Upside of 1663.16%

Current:

$0.95

Target:

$16.75

Insights on Bone Biologics

Price Movement
In the last 7 days, BBLG stock has moved down by -14.3%
BBLG vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 62.7% return, outperforming this stock by 135.2%
BBLG vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 113.2% return, outperforming this stock by 213.1%

Bone Biologics Technicals Summary

Sell

Neutral

Buy

Bone Biologics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Bone Biologics Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Bone Biologics Corp	-28.56%	-26.22%	-85.0%	-99.89%	-99.93%
Stryker Corporation	-4.47%	8.97%	23.96%	36.93%	77.64%
Boston Scientific Corp.	0.35%	18.26%	61.82%	110.62%	102.42%
Edwards Lifesciences Corp.	4.59%	-18.39%	-1.73%	-41.72%	-2.7%
Abbott Laboratories	-3.52%	10.44%	3.95%	-18.3%	32.21%
Medtronic Plc	-5.48%	3.6%	-1.44%	-21.99%	-27.8%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Bone Biologics Corp	0.09	NA	0.0	-5.0	-1.19	-0.57	NA	5.44
Stryker Corporation	39.7	39.7	2.56	12.06	0.19	0.07	0.01	52.86
Boston Scientific Corp.	75.26	75.26	1.65	2.46	0.09	0.05	NA	14.05
Edwards Lifesciences Corp.	29.1	29.1	6.92	2.55	0.19	0.11	NA	16.18
Abbott Laboratories	34.88	34.88	2.22	4.68	0.15	0.06	0.02	22.94
Medtronic Plc	24.94	24.94	1.49	5.2	0.08	0.04	0.03	38.29

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Bone Biologics Corp	Buy	$2.2M	-99.93%	0.09	0.0%
Stryker Corporation	Buy	$141.3B	77.64%	39.7	16.34%
Boston Scientific Corp.	Buy	$134.2B	102.42%	75.26	11.26%
Edwards Lifesciences Corp.	Buy	$44.5B	-2.7%	29.1	65.86%
Abbott Laboratories	Buy	$199.0B	32.21%	34.88	13.99%
Medtronic Plc	Buy	$104.6B	-27.8%	24.94	12.06%

About Bone Biologics

a publicly-held biotechnology company that is a spin off of the musculoskeletal transplant foundation (mtf) using technology discovered and licensed from ucla. bone biologics market and focus is in the regenerative medicine orthobiologics space. bone biologics was founded in 2004 by university of california professors in collaboration with an osaka university professor and a usc surgeon and acquired in 2006 by mtf as the major shareholder, who has been the primary funder since the acquisition. the company’s proprietary, patented platform technology ucb-1™, exclusively licensed from ucla, has met and surpassed existing standards of care outcomes in completed large animal model (sheep and rhesus monkey) studies that have demonstrated that the ucb-1™ technology facilitates superior normal bone growth. the company believes that as a platform technology, ucb-1™ has broad applications in delivering improved outcomes in almost all surgical procedures involved in bone repair and regeneration.

Organization	Bone Biologics
Employees	2
CEO	Mr. Jeffrey Frelick
Industry	Biotechnology

Management People of Bone Biologics

Name	Title
Mr. Jeffrey Frelick	CEO & President

Important FAQs about investing in Bone Biologics from India :

What is Bone Biologics share price today?

Bone Biologics share price today stands at $0.95, Open: $0.90 ; Previous Close: $0.90 ; High: $0.96 ; Low: $0.88 ; 52 Week High: $10.56 ; 52 Week Low: $0.80. The stock opens at $0.90, after a previous close of $0.90. The stock reached a daily high of $0.96 and a low of $0.88, with a 52-week high of $10.56 and a 52-week low of $0.80.

Can Indians buy Bone Biologics shares?

Yes, Indians can invest in the Bone Biologics (BBLG) from India.

With INDmoney, you can buy Bone Biologics at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Bone Biologics at zero transaction cost.

How can I buy Bone Biologics shares from India?

It is very easy to buy Bone Biologics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Bone Biologics be purchased?

Yes, you can buy fractional shares of Bone Biologics with INDmoney app.

What are the documents required to start investing in Bone Biologics stocks?

To start investing in Bone Biologics, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.